Copyright Reports & Markets. All rights reserved.

Global Respiratory Syncytial Virus Vaccine for Children Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Respiratory Syncytial Virus Vaccine for Children Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Recombinant Protein Vaccine
    • 1.3.3 Nucleic Acid Vaccine
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Respiratory Syncytial Virus Vaccine for Children Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Centers for Disease Control and Prevention
    • 1.4.4 Others
  • 1.5 Global Respiratory Syncytial Virus Vaccine for Children Market Size & Forecast
    • 1.5.1 Global Respiratory Syncytial Virus Vaccine for Children Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Respiratory Syncytial Virus Vaccine for Children Sales Quantity (2021-2032)
    • 1.5.3 Global Respiratory Syncytial Virus Vaccine for Children Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Moderna
    • 2.1.1 Moderna Details
    • 2.1.2 Moderna Major Business
    • 2.1.3 Moderna Respiratory Syncytial Virus Vaccine for Children Product and Services
    • 2.1.4 Moderna Respiratory Syncytial Virus Vaccine for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Moderna Recent Developments/Updates
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Respiratory Syncytial Virus Vaccine for Children Product and Services
    • 2.2.4 Sanofi Respiratory Syncytial Virus Vaccine for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sanofi Recent Developments/Updates
  • 2.3 Meissa
    • 2.3.1 Meissa Details
    • 2.3.2 Meissa Major Business
    • 2.3.3 Meissa Respiratory Syncytial Virus Vaccine for Children Product and Services
    • 2.3.4 Meissa Respiratory Syncytial Virus Vaccine for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Meissa Recent Developments/Updates
  • 2.4 Blue Lake Biotechnology
    • 2.4.1 Blue Lake Biotechnology Details
    • 2.4.2 Blue Lake Biotechnology Major Business
    • 2.4.3 Blue Lake Biotechnology Respiratory Syncytial Virus Vaccine for Children Product and Services
    • 2.4.4 Blue Lake Biotechnology Respiratory Syncytial Virus Vaccine for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Blue Lake Biotechnology Recent Developments/Updates
  • 2.5 Codagenix
    • 2.5.1 Codagenix Details
    • 2.5.2 Codagenix Major Business
    • 2.5.3 Codagenix Respiratory Syncytial Virus Vaccine for Children Product and Services
    • 2.5.4 Codagenix Respiratory Syncytial Virus Vaccine for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Codagenix Recent Developments/Updates
  • 2.6 Novavax
    • 2.6.1 Novavax Details
    • 2.6.2 Novavax Major Business
    • 2.6.3 Novavax Respiratory Syncytial Virus Vaccine for Children Product and Services
    • 2.6.4 Novavax Respiratory Syncytial Virus Vaccine for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Novavax Recent Developments/Updates
  • 2.7 Pfizer
    • 2.7.1 Pfizer Details
    • 2.7.2 Pfizer Major Business
    • 2.7.3 Pfizer Respiratory Syncytial Virus Vaccine for Children Product and Services
    • 2.7.4 Pfizer Respiratory Syncytial Virus Vaccine for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Pfizer Recent Developments/Updates
  • 2.8 Wits Health Consortium (Pty) Ltd
    • 2.8.1 Wits Health Consortium (Pty) Ltd Details
    • 2.8.2 Wits Health Consortium (Pty) Ltd Major Business
    • 2.8.3 Wits Health Consortium (Pty) Ltd Respiratory Syncytial Virus Vaccine for Children Product and Services
    • 2.8.4 Wits Health Consortium (Pty) Ltd Respiratory Syncytial Virus Vaccine for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Wits Health Consortium (Pty) Ltd Recent Developments/Updates
  • 2.9 Advaccine
    • 2.9.1 Advaccine Details
    • 2.9.2 Advaccine Major Business
    • 2.9.3 Advaccine Respiratory Syncytial Virus Vaccine for Children Product and Services
    • 2.9.4 Advaccine Respiratory Syncytial Virus Vaccine for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Advaccine Recent Developments/Updates
  • 2.10 Clover Biopharma
    • 2.10.1 Clover Biopharma Details
    • 2.10.2 Clover Biopharma Major Business
    • 2.10.3 Clover Biopharma Respiratory Syncytial Virus Vaccine for Children Product and Services
    • 2.10.4 Clover Biopharma Respiratory Syncytial Virus Vaccine for Children Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Clover Biopharma Recent Developments/Updates

3 Competitive Environment: Respiratory Syncytial Virus Vaccine for Children by Manufacturer

  • 3.1 Global Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Respiratory Syncytial Virus Vaccine for Children Revenue by Manufacturer (2021-2026)
  • 3.3 Global Respiratory Syncytial Virus Vaccine for Children Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Respiratory Syncytial Virus Vaccine for Children by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Respiratory Syncytial Virus Vaccine for Children Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Respiratory Syncytial Virus Vaccine for Children Manufacturer Market Share in 2025
  • 3.5 Respiratory Syncytial Virus Vaccine for Children Market: Overall Company Footprint Analysis
    • 3.5.1 Respiratory Syncytial Virus Vaccine for Children Market: Region Footprint
    • 3.5.2 Respiratory Syncytial Virus Vaccine for Children Market: Company Product Type Footprint
    • 3.5.3 Respiratory Syncytial Virus Vaccine for Children Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Respiratory Syncytial Virus Vaccine for Children Market Size by Region
    • 4.1.1 Global Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Respiratory Syncytial Virus Vaccine for Children Consumption Value by Region (2021-2032)
    • 4.1.3 Global Respiratory Syncytial Virus Vaccine for Children Average Price by Region (2021-2032)
  • 4.2 North America Respiratory Syncytial Virus Vaccine for Children Consumption Value (2021-2032)
  • 4.3 Europe Respiratory Syncytial Virus Vaccine for Children Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Consumption Value (2021-2032)
  • 4.5 South America Respiratory Syncytial Virus Vaccine for Children Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Type (2021-2032)
  • 5.2 Global Respiratory Syncytial Virus Vaccine for Children Consumption Value by Type (2021-2032)
  • 5.3 Global Respiratory Syncytial Virus Vaccine for Children Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Application (2021-2032)
  • 6.2 Global Respiratory Syncytial Virus Vaccine for Children Consumption Value by Application (2021-2032)
  • 6.3 Global Respiratory Syncytial Virus Vaccine for Children Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Type (2021-2032)
  • 7.2 North America Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Application (2021-2032)
  • 7.3 North America Respiratory Syncytial Virus Vaccine for Children Market Size by Country
    • 7.3.1 North America Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Respiratory Syncytial Virus Vaccine for Children Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Type (2021-2032)
  • 8.2 Europe Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Application (2021-2032)
  • 8.3 Europe Respiratory Syncytial Virus Vaccine for Children Market Size by Country
    • 8.3.1 Europe Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Respiratory Syncytial Virus Vaccine for Children Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Market Size by Region
    • 9.3.1 Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Type (2021-2032)
  • 10.2 South America Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Application (2021-2032)
  • 10.3 South America Respiratory Syncytial Virus Vaccine for Children Market Size by Country
    • 10.3.1 South America Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Respiratory Syncytial Virus Vaccine for Children Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Market Size by Country
    • 11.3.1 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Respiratory Syncytial Virus Vaccine for Children Market Drivers
  • 12.2 Respiratory Syncytial Virus Vaccine for Children Market Restraints
  • 12.3 Respiratory Syncytial Virus Vaccine for Children Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Respiratory Syncytial Virus Vaccine for Children and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Respiratory Syncytial Virus Vaccine for Children
  • 13.3 Respiratory Syncytial Virus Vaccine for Children Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Respiratory Syncytial Virus Vaccine for Children Typical Distributors
  • 14.3 Respiratory Syncytial Virus Vaccine for Children Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Respiratory Syncytial Virus Vaccine for Children market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Respiratory Syncytial Virus Vaccine for Children market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Respiratory Syncytial Virus Vaccine for Children market size and forecasts, in consumption value ($ Million), sales quantity (Dose), and average selling prices (US$/Dose), 2021-2032
    Global Respiratory Syncytial Virus Vaccine for Children market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Dose), and average selling prices (US$/Dose), 2021-2032
    Global Respiratory Syncytial Virus Vaccine for Children market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Dose), and average selling prices (US$/Dose), 2021-2032
    Global Respiratory Syncytial Virus Vaccine for Children market shares of main players, shipments in revenue ($ Million), sales quantity (Dose), and ASP (US$/Dose), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Respiratory Syncytial Virus Vaccine for Children
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Respiratory Syncytial Virus Vaccine for Children market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Sanofi, Meissa, Blue Lake Biotechnology, Codagenix, Novavax, Pfizer, Wits Health Consortium (Pty) Ltd, Advaccine, Clover Biopharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Respiratory Syncytial Virus Vaccine for Children market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Recombinant Protein Vaccine
    Nucleic Acid Vaccine
    Others
    Market segment by Application
    Hospital
    Centers for Disease Control and Prevention
    Others
    Major players covered
    Moderna
    Sanofi
    Meissa
    Blue Lake Biotechnology
    Codagenix
    Novavax
    Pfizer
    Wits Health Consortium (Pty) Ltd
    Advaccine
    Clover Biopharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Respiratory Syncytial Virus Vaccine for Children product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Respiratory Syncytial Virus Vaccine for Children, with price, sales quantity, revenue, and global market share of Respiratory Syncytial Virus Vaccine for Children from 2021 to 2026.
    Chapter 3, the Respiratory Syncytial Virus Vaccine for Children competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Respiratory Syncytial Virus Vaccine for Children breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Respiratory Syncytial Virus Vaccine for Children market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Respiratory Syncytial Virus Vaccine for Children.
    Chapter 14 and 15, to describe Respiratory Syncytial Virus Vaccine for Children sales channel, distributors, customers, research findings and conclusion.

    Buy now